| Financial Year |
March 31 2023 |
| Monetary Funds |
1,419,105,594.23 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
330,027,923.59 |
| Accounts Receivable |
515,476,553.08 |
| Advances to Suppliers |
258,951,071.21 |
| Other Receivables |
66,973,460.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,883,189,288.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
43,306,211.47 |
| Total Current Assets |
6,665,545,006.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
8,715,589,204.07 |
| Under-construction Projects |
140,493,451.45 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
679,690,719.76 |
| R&D expenses |
-- |
| Goodwill |
214,938,282.05 |
| Long-Term Deferred and Prepaid Expenses |
4,567,149.14 |
| Deferred Income Tax Assets |
27,789,619.04 |
| Other Non-Current Assets |
87,523,555.22 |
| Sub-Total of Non-Current Assets |
9,905,969,472.87 |
| Total Assets |
16,571,514,479.26 |
| Short-Term Loans |
2,579,507,350.01 |
| Trading Financial liabilities |
212,593,253.26 |
| Notes Payable |
665,118,298.58 |
| Accounts Payable |
1,138,303,201.13 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
79,687,707.32 |
| Taxes Payable |
121,093,154.89 |
| Interest Payable |
-- |
| Dividend Payable |
6,463,729.87 |
| Other payables |
947,474,401.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,178,888,466.68 |
| Other Current Liabilities |
287,655,311.62 |
| Sub-Total of Current Liabilities |
7,460,102,285.47 |
| Long-term Loans |
1,573,941,179.09 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
240,074,848.48 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
159,916,450.13 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,049,632,227.80 |
| Total Liabilities |
9,509,734,513.27 |
| Paid-In Capital(Or Share Stock) |
1,661,472,616.00 |
| Capital Surplus |
4,687,799,232.44 |
| Surplus Reserve |
16,570,647.81 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
627,605,938.17 |
| Minority Stockholder's Interest |
49,977,694.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,011,802,271.36 |
| Owner's Equity（Stockholder's Equity） |
7,061,779,965.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,571,514,479.26 |
